IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 2542 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  Navigate here 
  Search
 
 # Next article
 # Previous article 
 # Table of Contents
  
 Resource links
 #  Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
 #  Article in PDF (65 KB)
 #  Citation Manager
 #  Access Statistics
 #  Reader Comments
 #  Email Alert *
 #  Add to My List *
* Registration required (free)  


  In this article
 #  References

 Article Access Statistics
    Viewed3318    
    Printed59    
    Emailed1    
    PDF Downloaded213    
    Comments [Add]    
    Cited by others 1    

Recommend this journal

 
LETTER TO EDITOR
Year : 2003  |  Volume : 69  |  Issue : 4  |  Page : 314-
 

Treatment of pemphigus


M-54, Lajpat Nagar II, New Delhi - 110024

Correspondence Address:
M-54, Lajpat Nagar II, New Delhi - 110024
dr_ramji@yahoo.com



How to cite this article:
Gupta R, Gupta S. Treatment of pemphigus . Indian J Dermatol Venereol Leprol 2003;69:314


How to cite this URL:
Gupta R, Gupta S. Treatment of pemphigus . Indian J Dermatol Venereol Leprol [serial online] 2003 [cited 2019 Oct 19];69:314. Available from: http://www.ijdvl.com/text.asp?2003/69/4/314/5010


Sir,
It was interesting to read the article by Balachandran.[1] I wish to point out certain discrepancies.

1. There are only 25 references mentioned in the reference section while 26 are quoted in the text. The references in the text should have been 6 to 25 instead of 7 to 26.

2. After successful treatment of Reiter's disease with dexamethasone pulse,[2] we started using dexamethasone-cyclophosphamide pulse (DCP) therapy for treating pemphigus since 1982[3] and not since1992 as quoted. Subsequently many more reports were published in different journal. [4],[5],[6]

3. The transfusion duration is 1-1.5 hours instead of 3-4 hours. The second phase of therapy is now modified to 9 pulses in place of 6. Similarly the third phase is of 9 months in place of 1 year.

4. Among the side effects quoted, viz. infection leading to septicaemia, I wish to clarify that infection does not lead to septicemia if appropriate antibiotic therapy is instituted prior to or even during the pulse therapy.

5. Most of the reports by Indian workers published in our journal have not been reviewed.
 

  #   References Top

1.Balachandran C. Treatment of pemphigus. Indian J Dermatol Venereol Leprol 2003;69:3-5.   Back to cited text no. 1    
2.Pasricha JS, Gupta R. Pulse therapy with dexamethasone in Reiter's disease. Indian J Dermatol Venereol Leprol 1982;48:358-361.  Back to cited text no. 2    
3.Pasricha JS, Gupta R. Pulse therapy with dexamethasone-cyclophosphamide in pemphigus. Indian J Dermatol Venereol Leprol 1984;50:199-203.  Back to cited text no. 3    
4.Pasricha JS, Thanzama J, Khan UK. Intermittent high dose dexamethasone-cyclophosphamide pulse therapy for pemphigus. Br J Dermatol 1988;119:73-77.  Back to cited text no. 4    
5.Pasricha JS, Seetharam KA, Das U. Further studies on pemphigus patients treated with dexamethasone-cyclophosphamide pulse therapy. Ind J Dermatol Venereol Leprol 1989;55:98-104.  Back to cited text no. 5    
6.Pasricha JS, Das SS. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris. Int J Dermatol 1992;31:875-877.   Back to cited text no. 6    

 

Top
Print this article  Email this article

    

Online since 15th March '04
Published by Wolters Kluwer - Medknow